A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(53 sites)
United States
Alabama Oncology, Birmingham, Alabama Mayo Clinic Hospital, Phoenix, Arizona Beverly Hills Cancer Center, Beverly Hills, California MemorialCare Orange Coast Medical Center, Fountain Valley, California City of Hope at Orange County Lennar Foundation Cancer Center, Irvine, California LA Cancer Network, Los Angeles, California UCLA Department of Medicine - Hematology/Oncology, Los Angeles, California University of California San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center, San Francisco, California University of Colorado School of Medicine, Aurora, Colorado Yale University, Yale Cancer Center, New Haven, Connecticut Mayo Clinic Florida, Jacksonville, Florida Cancer Specialists of North Florida, Jacksonville, Florida Moffitt Cancer Center, Tampa, Florida Winship Cancer Institute, Emory University, Atlanta, Georgia University of Illinois Cancer Center, Chicago, Illinois The University of Chicago, Chicago, Illinois Massachusetts General Hospital, Boston, Massachusetts Dana-Farber Cancer Institute, Boston, Massachusetts University of Minnesota, Masonic Cancer Center, Minneapolis, Minnesota Mayo Clinic, Rochester, Minnesota Missouri Cancer Associates, Columbia, Missouri Saint Luke's Cancer Institute, Kansas City, Missouri Oncology Hematology Associates, Springfield, Missouri Washington University School of Medicine, St Louis, Missouri Cancer Care Specialists, Reno, Nevada University of Rochester Medical Center, Rochester, New York UNC Hospitals, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina The Ohio State University, Stefanie Spielman Comprehensive Breast Center, Columbus, Ohio Taylor Cancer Research Center, Maumee, Ohio Alliance Cancer Specialists, Horsham, Pennsylvania University of Pennsylvania, Abramson Cancer Center, Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania University of Pittsburgh (UPMC), Pittsburgh, Pennsylvania Tennessee Oncology, Greco-Hainsworth Center for Research, Nashville, Tennessee Texas Oncology, Dallas, Texas Virginia Cancer Institute, Richmond, Virginia Portugal
Instituto Português de Oncologia de Lisboa Francisco Gentil (IPO Lisboa), Lisbon Fundação Champalimaud, Lisbon Hospital CUF Descobertas, Lisbon Instituto Português Oncologia Do Porto, Porto Spain
Hospital General Universitario Dr. Balmis, Alicante Hospital Universitario de Cruces, Barakaldo Hospital Universitario Vall d'Hebron, Barcelona Hospital Clínico de Barcelona, Barcelona Hospital Universitario de Basurto, Bilbao Hospital San Pedro de Alcántara, Cáceres Hospital San Cecilio, Granada Hospital Universitario Juan Ramon Jimenez, Huelva Hospital Universitario de Jaén, Jaén Hospital Universitario Arnau de Vilanova, Lleida Hospital Universitario Fundación Jiménez Díaz, Madrid Hospital Universitario Virgen del Rocío, Seville Fundación Instituto Valenciano de Oncología (IVO), Valencia Hospital Clínico Universitario de Valencia, Valencia